Serum Concentrations of IgG4 in the Spanish Adult Population: Relationship with Age, Gender, and Atopy

PLoS One. 2016 Feb 24;11(2):e0149330. doi: 10.1371/journal.pone.0149330. eCollection 2016.

Abstract

Background and aim: Serum IgG4 concentrations are commonly measured in clinical practice. The aim of this study was to investigate serum IgG4 concentrations in adults and their potential relationship with demographic, lifestyle, metabolic, and allergy-related factors.

Methods: Serum IgG4 concentrations were measured with a commercial assay in 413 individuals (median age 55 years, 45% males) who were randomly selected from a general adult population.

Results: Median IgG4 concentration was 26.8 mg/dL. Five out of the 413 individuals (1.2%) exhibited IgG4 concentrations >135 mg/dL, and 17 out of 411 (4.1%) exhibited an IgG4/total IgG ratio >8%. Serum IgG4 concentrations were significantly higher in males than in females and decreased with age. After adjusting for age and sex, serum IgG4 concentrations were not significantly influenced by alcohol consumption, smoking or common metabolic abnormalities (obesity and the related metabolic syndrome). Serum IgG4 concentrations were not significantly correlated with serum concentrations of proinflammatory cytokines and inflammation markers. Serum IgG4 concentrations were significantly correlated with IgE concentrations. Serum IgG4 concentrations tended to be higher in atopics (individuals with IgE-mediated sensitization to aeroallergens) than in non-atopics, particularly among atopics without respiratory symptoms. Serum IgG4 concentrations were not significantly correlated with total eosinophil blood count. Cases of IgG4-related disease were neither present at baseline nor detected after a median of 11 years of follow-up.

Conclusions: Studies aimed at defining reference IgG4 values should consider partitioning by age and sex. Further studies are needed to confirm the potential influence of atopy status on serum IgG4 concentrations.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aging / blood*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypersensitivity / blood*
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Sex Characteristics*
  • Spain

Substances

  • Immunoglobulin G

Grants and funding

The study was supported by grants from the Instituto de Salud Carlos III, Spanish Ministry of Health (PI13/02594 and Red de Investigación en Actividades Preventivas y Promoción de la Salud, redIAPP RD12/0005/0007), Fondo Europeo de Desarrollo Regional (FEDER), and the Consellería de Innovación e Industria, Xunta de Galicia (PGIDIT06PXIB918313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.